We are committed to finding a cure for WM.
2019 WMFC Educational Forum Presentation – Dr. Castillo
Dr. Jorge Castillo – Associate Professor of Medicine, Harvard University – presenting “Treatment around the corner for Waldenstroms Macroglobulinemia” at the 2019 WMFC Educational Forum Toronto – April 2019
2019 WMFC Educational Forum Presentation – Dr. Chen
Dr. Christine Chen from the Princess Margaret Cancer Centre presenting on ” Navigating Treatment Options for Waldenstrom’s Macroglobulinemia in Canada” at the 2019 WMFC Educational Forum Toronto – April 2019
2019 WMFC Educational Forum Presentation – Dr. Carrasco
Dr. Ruben Carrasco from the Department of Pathology, BWH and Department of Oncologic Pathology, DFCI presenting: Engineering a mouse model of Lymphoplasmacytic Lymphoma/Waldenstroms Macroglobulinemia (LPL/WM) at the 2019 WMFC Educational Forum Toronto – April 2019
2019 WMFC Educational Forum Presentation – Dr. Treon
Dr. Steven Treon – Bing Center for Waldenstroms Macroglobulinemia, Dana Farber Cancer Institute, Harvard Medical School
Presenting: Waldenstroms Macroglobulinemia: Genomic Based Treatment Advances
2019 WMFC Educational Forum Presentation – Dr. Matous
Dr. Jeffery Matous, Colorado Blood Cancer Institute
Presenting: Waldenstroms Macroglobulinemia: Basic Training for Patients
Care for the Caregiver
Caregivers are often putting faced with putting the needs of others above their own. It is being more widely acknowledged how damaging this can be on both the caregiver and the patients. Emotionally and physically.
The Leukemia… Continue reading
Cure Talks Cancer Podcast: MPN HEROES MAKE A DIFFERENCE IN THE RARE BLOOD CANCER SPACE
From the Cure Talks Cancer, this podcast features interviews with patients, survivors, caregivers, advocates and health care professionals
To read more, visit https://www.curetoday.com/articles/cure-honors-nine-who-help-people-with-rare-blood-cancers
Source: https://audioboom.com/posts/7146894-mpn-heroes-make-a-difference-in-the-rare-blood-cancer-space
Article: LOXO-305 Trial Begins for Lymphoma, Leukemia Patients Resistant to BTK Inhibitors
Source: Lymphoma News Today
A Phase 1/2 trial is evaluating Loxo Oncology‘s BTK inhibitor LOXO-305 in leukemia and lymphoma patients who failed, or were intolerant to, approved BTK inhibitors.
The trial, so far being conducted… Continue reading
WM Cancercare Webinar – April 10th
Join Dr. Stephen Ansell from Mayo Clinic, Dr. Jorge Castillo from Dana Farber and Carl Harrington from IWMF for this Cancercare webinar on
Wednesday, April 10
1:30pm Atlantic
FREE
Registration required
Listen in by phone or online
REGISTERHerbert Eradat – 2018 Lymphoma Research Foundation (LRF) Annual North American Educational Forum on Lymphoma
Herbert Eradat, MD, MS, Director of Program in CLL & Waldenstrom’s Macroglobulinemia, UCLA Lymphoma & BMT/CAR-T Cell Program, Associate Professor of Medicine, David Geffen School of Medicine presented the following at the 2018 Lymphoma Research Foundation (LRF) Annual North American… Continue reading
